Oral and Poster Presentations
Our research team produces oral and poster presentations in support of our research clients.
Burden of Illness
Costs and Absences Associated with Rheumatoid Arthritis On Work Productivity: A Comparison Between Employees with and without Rheumatoid Arthritis In a United States Population.
Kleinman NL, Brook RA, Kirbach SE, Cifaldi MA
Poster Presentation at the American College of Rheumatology’s 2011 Annual Scientific Meeting.
November 7, 2011. Chicago, Illinois
Costs, Absences, Prevalence and Impact of Bipolar Disorder, Other Mental Disorders, Chronic Constipation, Functional Dyspepsia, GERD, Gout, and Insomnia
Brook RA, Kleinman NL
Poster Presentation at the Academy of Managed Care Pharmacy’s 2011 Educational Conference
October 19-21, 2011. Atlanta, Georgia
Impact of Rheumatoid Arthritis on Health Care Costs and Work Productivity: A Comparative Assessment with Diabetes and Depression
Brook RA, Roy S, Kleinman NL, Cifaldi MA
Poster Presentation and Poster Tour at the Annual European Congress of Rheumatology (EULAR) 2011
May 26, 2011. London, United Kingdom
The Likelihood of Having Functional Dyspepsia Based on Other Comorbid Conditions
Brook RA, Talley NJ, Choung RS, Smeeding J, Kleinman NL
Poster Presentation at the ISPOR 16th Annual International Meeting 2011
May 25, 2011, Baltimore, MD
Neck or Back Pain with Neuropathic Component Associated with Greater Clinical Complexity and Medical Cost
Kleinman N, Patel A, Benson C, Abouzaid S, Macario A, Biondi D, Kim M
Poster Presentation at the American Society of Regional Anesthesia and Pain Medicine 2010 Annual Pain Medicine Meeting and Workshops
November 18-21, 2010, Phoenix, AZ
Burden of Employee Neck or Back Pain Without and With a Neuropathic Pain Component
Kleinman N, Patel A, Benson C, Abouzaid S, Macario A, Biondi D, Kim M
Poster Presentation at the American Academy of Pain Management 21st Annual Clinical Meeting 2010, Poster #54
September 23, 2010, Las Vegas, NV
Prevalence, Costs and Services of Comorbid Conditions Associated with Functional Dyspepsia
Brook RA, Talley NJ, Choung RS, Smeeding J, Melkonian AK, Kleinman NL
ISPOR 15th Annual International Meeting 2010, Poster #PGI3
May 17, 2010, Atlanta, GA
Functional Dyspepsia Decrease Productivity and Increased Medical Costs
Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding J, Talley NJ
ISPOR 15th Annual International Meeting, 2010, Poster #PGI12
May 17, 2010, Atlanta, GA
Direct Medical Costs and the Likelihood of Health Service Utilization Before and After Initiation of Avonex (Interferon Beta1A-IM) Treatment among Persons with Multiple Sclerosis (MS)
Brook RA, Rajagopalan K, Kleinman NL, Beren IA
International Society of Pharmacoeconomics and Outcomes Research 14th Annual International Meeting
May 20, 2009, Orlando, FL
Direct Medical Costs and the Likelihood of Health Service Utilization Before and After Initiation of Avonex (Interferon β1a IM) Treatment Among Persons with Multiple Sclerosis (MS)
Brook RA, Rajagopalan K, Kleinman NL, Beren I
Consortium of MS Centers’ 23rd Annual Meeting
May 27-30, 2009, Atlanta, GA
Cost of Illness for Fibromyalgia in the Workforce: Medical, Pharmacy, and Absence Cost Comparisons in Employees with or without Fibromyalgia
Kleinman NL, Lynch W, Melkonian AK, Harnett J, Andrews L, Silverman S
ACOEM Conference
April 28, 2009, San Diego, CA
Annual Direct and Indirect Cost of Illness in Employees with Irritable Bowel Syndrome plus Constipation
Brook R, Kleinman N, Melkonian A, Baran R
American College of Gastroenterology
October 3-8, 2008, Orlando, FL
The Prevalence and Costs to Treat Comorbidities in Persons with Constipation and Irritable Bowel Syndrome with Constipation in the 6 Months After Diagnosis: An Employer’s Perspective
Brook R, Kleinman N, Melkonian A, Talley N, Locke GR, Baran R
American College of Gastroenterology
October 3-8, 2008, Orlando, FL
Health Benefit Costs Among Employees With Multiple Sclerosis
Kleinman N, Rajagopalan K, Brook R, Melkonian A
Consortium of Multiple Sclerosis Centers
May 30, 2008, Denver, CO
Pediatric Asthma: An Employer Perspective on Annual Employee and Dependent Costs for Medical Care and Prescription Drugs
Kleinman N, Brook R, Ramachandran S, Wagner S
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting
May 6, 2008, Toronto, Ontario, Canada
Prevalence and Costs of Comorbidities Among Persons with and without Multiple Sclerosis: An Analysis of the AHRQ Major and Specific Diagnostic Categories
Brook R, Rajagopalan K, Kleinman N, Melkonian A
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting
May 5, 2008, Toronto, Ontario, Canada
Severity of Illness Among Persons with Multiple Sclerosis: An Analysis of Cost Quintiles
Kleinman N, Rajagopalan K, Brook R, Melkonian A
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting
May 5, 2008, Toronto, Ontario, Canada
Comparisons of Relative Risks of Serious Comorbidities Among Employees with and without Insomnia, GERD, Hepatitis C, Multiple Sclerosis and Chronic Constipation
Brook R, Kleinman N, Melkonian A, Smeeding J
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting
May 5, 2008, Toronto, Ontario, Canada
Direct cost similarities by point of service for persons with Constipation and Irritable Bowel Syndrome with Constipation in the 6 Months Before and After Diagnosis: An employer perspective
Kleinman N, Brook R, Melkonian A, Evans S, Talley N, Baran R
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting
May 5, 2008, Toronto, Ontario, Canada
An analysis of health benefit utilization among employees with immune-mediated inflammatory diseases
Waters H, Kleinman N, Borden S, Lynch W, Gardner H, Rahman M
Academy of Managed Care Pharmacy 20th Annual Meeting
April 16-19, 2008, San Francisco, CA
Measuring The Impact Of Cardio-Metabolic Syndrome In An Employed Population And The Relationship Between Performance Compensation And Pharmacy Compliance
Schaneman J, Kleinman N, Gardner H, Hoffman B.
8th Annual Health Services & Outcomes Research Conference
Kelsey Research Foundation
November 7, 2007, Houston, TX
Healthcare Cost Comparisons by Point-of-Service for Employees with or without Insomnia
Brook R, Kleinman N, Melkonian A, Doan J, Baran R
Poster Presentation at the Academy of Managed Care Pharmacy's (AMCP) 2007 Education Conference
October 24 - 27, 2007, Boston, MA
Objective Costs and Prevalence of Comorbidities for Persons with and without Insomnia
Doan J, Brook R, Kleinman N, Melkonian A, Smeeding J, Baran R
Poster Presentation at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Congress
October 22, 2007, Dublin, Ireland
Medical, Pharmacy, and Sick Leave Costs for Constipation and for Irritable Bowl Syndrome with Constipation in the 6 Months Before and After Diagnosis: An Employer Perspective
Kleinman N, Brook R, Melkonian A, Baran R, Talley N
Poster Presentation at the American College of Gastroenterology Scientific Meeting
October 2007, Philadephia, PA
Functional Gastrointestinal Disorder Comorbidities: Comparisons of Prevalence and Costs in the 6 Months Before and After Diagnoses of Constipation (C) and Irritable Bowel Syndrome and Constipation
Brook R, Talley N, Kleinman N, Baran R
Poster Presentation at the American College of Gastroenterology Scientific Meeting
October 2007, Philadelphia, PA
Cost of Illness for Insomnia: Medical, Pharmacy, and Work Absence Costs in Employees with and without Insomnia
Brook R, Kleinman N, Melkonian A, Doan J, Baran R
Poster Presentation at the Associated Professional Sleep Societies, Sleep 2007
June 2007, Minneapolis, MN
Comorbidities During the Year Following Diagnosis for Persons with and without GERD using the Agency for Health Research and Quality (AHRQ) 261 Specific Categories
Wallander M, Wahlqvist P, Kleinman N, Campbell S, Talley N, Brook R
Poster Presentation at the International Society of Pharmacoeconomics and Outcomes Research
May 2007, Arlington, VA
Direct Costs by Point of Service for Persons with and without Constipation: An Employer Perspective
Kleinman N, Brook R, Melkonian A, Baran R
Poster Presentation at the Academy of Managed Care Pharmacy 19th Spring Educational Meeting and Showcase
April 2007, San Diego, CA
Cost of Functional Dyspepsia - Results From a Large US Employer Database
George S, Kleinman N, Brook R, Smeeding J
Oral Podium Presentation at ISPOR's 9th Annual European Congress, Value in Health
Volume 9, Number 6, Pages A189-90, November/December 2006
October 30, 2006, Copenhagen, Denmark
Cost of Illness for Constipation: Medical, Pharmacy, and Work Absence Costs in Employees with or without Constipation
Brook R, Kleinman N, Melkonian A, Baran R
Poster Presentation at The American College of Gastroenterology Annual Scientific Meeting
September 2006, Las Vegas, NV
Cost of Illness of Gastroesophageal Reflux Disease (GERD): Comparison of Medical, Pharmacy, Sick Leave, Short-and Long-Term Disability, and Workers' Compensation Claims and Medical Claims by Place of Service Between Employees with and without GERD
Brook R, Campbell S, Wahlqvist P, Wallander M, Kleinman N, Wiklund I, Smeeding J
Oral Podium Presentation at Digestive Disease Week (The American Gastroenterological Association)
Gastroenterology
Volume 130, Number Suppl 2, Pages A-27
May 21, 2006, Los Angeles, CA
Lost Work Days and Emergency Department Visits Among Patients Treated for Bipolar Disorder
Brook R, Rajagopalan K, Novak S, Kleinman N, Smeeding J, Gardner H
Poster Presentation at the American Psychiatric Association
May 2006, Toronto, Canada; Arlington, VA
Impact of the ROME II Criteria - Assessment of Related Comorbid Prevalence and Costs of Patients with Functional Dyspepsia
George S, Kleinman N, Brook R, Smeeding J
Poster Presentation at Digestive Disease Week
May 2006, Los Angeles, CA
Cost of Illness in US Employees with and without Gastroesophageal Reflux Disease (GERD)
Brook R, Campbell S, Wahlqvist P, Wallander M, Kleinman N, Wiklund I, Smeeding J
Poster Presentation at the International Society of Pharmacoeconomics and Outcomes Research
May 2006, Philadelphia, PA
The Use of Quintile Analysis as a Measure of Disease Severity: A Comparison within and Across Diseases
Brook R, Kleinman N, Smeeding J, Rajagopalan K, Wahlqvist P, Joshua-Gotlib S, George S, Campbell S, Wingenbach D, Krueger K, Melkonian A, Novak S, Gardner H
Poster Presentation at the International Society of Pharmacoeconomics and Outcomes Research
May 2006, Philadelphia, PA
Annual Total Medical Costs for Bipolar Disorder Patients Treated with Antipsychotics
Brook R, Novak S, Kleinman N, Rajagopalan K, Gardner H, Smeeding J
Poster Presentation at the AMCP Spring Educational Meeting and Showcase
April 2006, Seattle, WA
A Comparison of Average Annual Medical Services for Comorbid Conditions Associated with Metabolic Syndrome Found in Employees with Gout Versus Those without Gout
Novak S, Patel P, Kleinman N, Brook R, Melkonian A, Smeeding J, Joseph-Ridge N
Poster Presentation at the AMCP Spring Educational Meeting and Showcase
April 2006, Seattle, WA
Cost Comparisons by Place of Service for Persons with and without Gout
Kleinman N, Patel P, Brook R, Melkonian A, Smeeding J, Joseph-Ridge N
Poster Presentation at the American Society of Health-System Pharmacists Midyear Clinical Meeting
December 2005, Las Vegas, NV
Economic Burden of Gout to the Employer
Kleinman N, Patel P, Brook R, Melkonian A, Smeeding J, Joseph-Ridge N
Poster Presentation at the Academy of Managed Care Pharmacy 2005 Educational Conference
October 2005, Nashville, TN
Physical and Mental Comorbidities among Employees with Bipolar Disorder: Analysis of AHRQ 261 Specific Categories
Kleinman N, Rajagopalan K, Brook R, Smeeding J, Gardner H
Poster Presentation at the American Psychiatric Association 2005 Annual Meeting
May 2005, Atlanta, GA
Physical and Mental Comorbidities among Employees with Bipolar Disorder: Analysis of Major Diagnostic Categories
Kleinman N, Gardner H, Rajagopalan K, Brook R, Smeeding J
Poster Presentation at the American Psychiatric Association 2005 Annual Meeting
May 2005, Atlanta, GA
Incremental Health Benefits Cost of Bipolar Disorder among Insured Employees
Kleinman N, Brook R, Gardner H, Rajagopalan K, Smeeding J
Poster Presentation at the American Psychiatric Association 2005 Annual Meeting
May 2005, Atlanta, GA
Incremental Health Benefits Cost of Bipolar Disorder among Insured Employees
Kleinman N, Gardner H, Rajagopalan K, Brook R, Smeeding J
Poster Presentation at the International Society for Pharmacoeconomics and Outcomes Research 10th Annual International Meeting
May 2005, Washington, DC
Physical and Mental Comorbidities among Employees with Bipolar Disorder: Analysis of AHRQ 261 Specific Categories
Kleinman N, Rajagopalan K, Brook R, Smeeding J, Gardner H
Poster Presentation at the Academy of Managed Care Pharmacy's 17th Annual Meeting and Showcase
April 2005, Denver, CO
Incremental Health Benefits Cost of Bipolar Disorder among Insured Employees
Kleinman N, Brook R, Gardner H, Rajagopalan K, Smeeding J
Poster Presentation at the Academy of Managed Care Pharmacy's 17th Annual Meeting and Showcase
April 2005, Denver, CO
Impact of Dependents’ Depression on Employee Health Benefits Cost: Quantifying the Burden of Care
Kleinman N, Muchmore L, Gardner H
Poster Presentation at Value in Health
Volume 6, Number 3, May, June 2003
International Society for Pharmacoeconomics and Outcomes Research © 2003
May, June 2003
Allergy Prevalence, Cost and Productivity Loss in an Insured Employee Population
Kleinman N, Muchmore L, Gardner H, Borden S
Poster Presentation at Value in Health
Volume 6, Number 3, May, June 2003
International Society for Pharmacoeconomics and Outcomes Research © 2003
May, June 2003
Family Caregiving Costs for Cancer Patients: A Multi-Employer Analysis
Cremieux P, Duh M, Birnbaum H, Petit P, Blasi M, Gardner H
Poster Presentation at Value in Health
Volume 5, Number 3, May, June 2002
Absence and Productivity
Costs and Absences Associated with Rheumatoid Arthritis On Work Productivity: A Comparison Between Employees with and without Rheumatoid Arthritis In a United States Population.
Kleinman NL, Brook RA, Kirbach SE, Cifaldi MA
Poster Presentation at the American College of Rheumatology’s 2011 Annual Scientific Meeting.
November 7, 2011. Chicago, Illinois
Costs, Absences, Prevalence and Impact of Bipolar Disorder, Other Mental Disorders, Chronic Constipation, Functional Dyspepsia, GERD, Gout, and Insomnia
Brook RA, Kleinman NL.
Poster Presentation at the Academy of Managed Care Pharmacy’s 2011 Educational Conference
October 19-21, 2011, Atlanta, Georgia
Impact of Rheumatoid Arthritis on Health Care Costs and Work Productivity: A Comparative Assessment with Diabetes and Depression
Brook RA, Roy S, Kleinman NL, Cifaldi MA
Poster Presentation and Poster Tour at the Annual European Congress of Rheumatology (EULAR) 2011
May 26, 2011, London, United Kingdom
Comparisons of Employee Worker’s Compensation Costs and Absence Days Using a National Database
Brook RA, Kleinman NL, Melkonian AK, Smeeding J
ISPOR 15th Annual International Meeting 2010, Poster #PHP45
May 18, 2010, Atlanta, GA
Functional Dyspepsia Decrease Productivity and Increased Medical Costs
Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding J, Talley NJ
ISPOR 15th Annual International Meeting, 2010, Poster #PGI12
May 17, 2010, Atlanta, GA
Work Absence and Absence Costs in Patients with Osteoarthritis and Low Back Pain in the United States
Pamela Vo, PharmD, MS, Richard Brook, MS, MBA, Nathan L. Kleinman, PhD, Scott A Strassels, PharmD, PhD, BCPS, James E Smeeding, PhD, Rh, MBA, Andrea Best DO, MPH, Earle Lockhart, MD, Steven Marx, PharmD, MS.
29th Annual Scientific Meeting of the American Pain Society, Poster #131, Abstract id #105
May 6-8, 2010, Baltimore, MD
Comparisons of Employee Workers’ Compensation Costs and Absence Days Using a National Database
Brook RA, Kleinman NL, Melkonian AK, Smeeding JE.
Presented at the Academy of Managed Care Pharmacy (AMCP) 22nd Annual Meeting and Showcase
April 7-10, 2010, San Diego, CA
Assessment of Indirect Costs and Absenteeism due to Sick Leave Before and After Treatment Initiation for Multiple Sclerosis (MS) in a US National Database
Rajagopalan K, Kleinman NL, Brook RA, Beren IA.
Presented at the 25th Congress of European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMs)
September 9 – 12, 2009, Düsseldorf, Germany
The Impact of Hepatitis-C Viral (HCV) Treatment on Work Absence and Productivity
Su J, Kleinman NL, Brook RA, Melkonian AK, Smeeding J, Corey-Lisle P
Digestive Disease Week
June 1, 2009, Chicago, IL
Hourly and Annual Objective Productivity (Presenteeism) across Several Diseases: Bipolar Disorder, Other Mental Disorders, Chronic Constipation, Functional Dyspepsia, GERD, Gout, and Insomnia
Brook RA, Kleinman NL, Melkonian AK, Smeeding J.
International Society of Pharmacoeconomics and Outcomes Research 14th Annual International Meeting
May 20, 2009, Orlando, FL
Incremental Sick Leave Costs and Lost Time among Employees with Psychiatric and Medical Conditions
Brook RA, Kleinman NL, Melkonian AK, Smeeding J.
International Society of Pharmacoeconomics and Outcomes Research 14th Annual International Meeting
May 19, 2009, Orlando, FL
The Impact of Multiple Sclerosis on Absenteeism
Brook R, Kleinman N, Rajagopalan K, Melkonian A
Consortium of Multiple Sclerosis Centers
May 30, 2008, Denver, CO
Impact of Anti-Tumor Necrosis Factor Therapies on Absence from Work Among Employees with Inflammatory Bowel Disease
Thompson H, Kleinman N, Borden S, Lynch W, Gardner H, Rahman M
Digestive Disease Week
May 17-22, 2008, San Diego, CA
Absenteeism (lost time) among employees with multiple sclerosis
Kleinman N, Brook R, Rajagopalan K, Melkonian A
Academy of Managed Care Pharmacy 20th Annual Meeting
April 16-19, 2008, San Francisco, CA
Work Productivity Loss Among those with Painful Conditions
Novak S, Joshua-Gotlib S, Kleinman N, Brook R, Krueger K, Smeeding J
Poster Presentation at the American Pain Society
May 2006, San Antonio, TX
Objective Measurement of Hourly and Annual Productivity While at Work in Employees with Gastroesophageal Reflux Disease (GERD) Compared with Employees Without GERD
Wahlqvist P, Brook R, Campbell S, Wallander M, Kleinman N, Wiklund I, Smeeding J
Poster Presentation at the Digestive Disease Week
May 2006, Los Angeles, CA
Objective Measurement of Productivity While at Work in US Employees with and without Gastroesophageal Reflux Disease (GERD)
Wahlqvist P, Brook R, Campbell S, Wallander M, Wiklund I, Kleinman N, Smeeding J
Poster Presentation at the International Society of Pharmacoeconomics and Outcomes Research
May 2006, Philadelphia, PA
Likelihood of Employment Termination for Employees with Bipolar Disorder Treated with Different Psychotropic Medications
Rajagopalan K, Kleinman N, Brook R, Smeeding J, Novak S, Gardner H
Poster Presentation at the International Society of Pharmacoeconomics and Outcomes Research
May 2006, Philadelphia, PA
Lost Days and Productivity Impact of Gout
Kleinman N, Patel P, Brook R, Melkonian A, Smeeding J, Joseph-Ridge N
Poster Presentation at the American College of Rheumatology 2005 Annual Meeting
November 2005, San Diego, CA
Allergy Prevalence, Cost and Productivity Loss in an Insured Employee Population
Kleinman N, Muchmore L, Gardner H, Borden S
Poster Presentation at the Value in Health
Volume 6, Number 3, May, June 2003
International Society for Pharmacoeconomics and Outcomes Research © 2003
May, June 2003
Treatment Comparison
Comparison of Direct Medical Costs and Services by Point of Service and Prescription Cost for Persons with Hepatitis-C with and without Treatment
Brook R, Kleinman N, Smeeding J
Poster Presentation at the ISPOR 16th Annual International Meeting 2011
May 25, 2011, Baltimore, MD,
Economic Impact of Ablation in Employees and Spouse Dependents with Atrial Fibrillation
Matthew R. Reynolds, Nicholas J. Rohrbacker, Nathan L. Kleinman, Sarah A. White, and Jamie March
Poster Presentation at Heart Rhythm 2010, Abstract #7263
Denver, Colorado, USA, May 12-15, 2010
Assessment of Indirect Costs and Absenteeism due to Sick Leave Before and After Treatment Initiation for Multiple Sclerosis (MS) in a US National Database
Rajagopalan K, Kleinman NL, Brook RA, Beren IA.
Presented at the 25th Congress of European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMs)
September 9 – 12, 2009 Düsseldorf, Germany
The Impact of Hepatitis-C Viral (HCV) Treatment on Work Absence and Productivity
Su J, Kleinman NL, Brook RA, Melkonian AK, Smeeding J, Corey-Lisle P
Digestive Disease Week
June 1, 2009, Chicago, IL
Direct Medical Costs and the Likelihood of Health Service Utilization Before and After Initiation of Avonex (Interferon Beta1A-IM) Treatment among Persons with Multiple Sclerosis (MS)
Brook RA, Rajagopalan K, Kleinman NL, Beren IA.
International Society of Pharmacoeconomics and Outcomes Research 14th Annual International Meeting
May 20, 2009, Orlando, FL
Direct Medical Costs and the Likelihood of Health Service Utilization Before and After Initiation of Avonex (Interferon β1a IM) Treatment Among Persons with Multiple Sclerosis (MS)
Brook RA, Rajagopalan K, Kleinman NL, Beren I.
Consortium of MS Centers’ 23rd Annual Meeting
May 27-30, 2009, Atlanta, GA.
Medication adherence and the direct medical and prescription cost impact of fixed dose vs loose dose thiazolidinedione combination products among type 2 diabetes patients
Brook R, Kleinman N, Wingenbach D, Bron M, Pandya B, Baran R
Academy of Managed Care Pharmacy 20th Annual Meeting
April 16-19, 2008, San Francisco, CA
Changes in Mental Health-Related Insurance Claims Costs Among Patients Treated for Bipolar Disorder
Kleinman N, Rajagopalan K, Brook R, Novak S, Smeeding J, Gardner H
Poster Presentation at the American Psychiatric Association
May 2006, Toronto, Canada; Arlington, VA
Likelihood of Employment Termination for Employees with Bipolar Disorder Treated with Different Psychotropic Medications
Rajagopalan K, Kleinman N, Brook R, Smeeding J, Novak S, Gardner H
Poster Presentation at the International Society of Pharmacoeconomics and Outcomes Research
May 2006, Philadelphia, PA
Annual Total Medical Costs for Bipolar Disorder Patients Treated with Antipsychotics
Brook R, Novak S, Kleinman N, Rajagopalan K, Gardner H, Smeeding J
Poster Presentation AMCP Spring Educational Meeting and Showcase
April 2006, Seattle, WA
Assessing Fracture Risk with Prescription Drugs in Medicare-Eligible Plan Members of a Telecommunications Company
Erwin G, Kleinman N, Astuto J, Gardner H, Lipson J, Stuart B, Wilson P
Poster Presentation at Value in Health
Volume 5, Number 3, May, June 2002
International Society for Pharmacoeconomics and Outcomes Research © 2003
May, June 202
Incidence and Cost Associated with Pharmacological Treatment for Employees Diagnosed with Urinary and Overactive Bladder Disorders
Muchmore L, Lynch W, Gardner H, Williamson T
Poster Presentation at Value in Health
Volume 5, Number 3, May, June 2002
International Society for Pharmacoeconomics and Outcomes Research © 2003
May, June 2002
Compliance and Outcomes
Medication Adherence with Disease Modifying Treatments For Multiple Sclerosis: Findings From a US National Database of Employees
Brook RA, Rajagopalan K, Kleinman NL, Beren IA.
Presented at ISPOR’s 12th Annual European Congress, Paris, France. October 24-27, 2009. Presentation as Poster PND30
October 26, 2009, Paris, France
Medication possession ratio and health benefit cost comparisons in type 2 diabetes patients using fixed- and loose-dose thiazolidinedione combination products
Brook R, Kleinman N, Wingenbach D, Bron M, Pandya B, Baran R
American Diabetes Association
June 6-10, 2008, San Francisco, CA
Medication adherence and the direct medical and prescription cost impact of fixed dose vs loose dose thiazolidinedione combination products among type 2 diabetes patients
Brook R, Kleinman N, Wingenbach D, Bron M, Pandya B, Baran R
Academy of Managed Care Pharmacy 20th Annual Meeting
April 16-19, 2008, San Francisco, CA
A comparison of employee cost share among anti tumor necrosis factor users
Waters H, Kleinman N, Borden S, Lynch W, Gardner H, Rahman M
Academy of Managed Care Pharmacy 20th Annual Meeting
April 16-19, 2008, San Francisco, CA
Benefits Design
Outcomes of a Community-based Clinical Prevention Service
Clarke P, Macnee C, Fiske M, Moore K, Rennick J, Campbell S
34th Annual American Academy of Nursing Meeting and Conference
November 9, 2007, Washington, DC
Measuring The Impact Of Cardio-Metabolic Syndrome In An Employed Population And The Relationship Between Performance Compensation And Pharmacy Compliance
Schaneman J, Kleinman N, Gardner H, Hoffman B.
8th Annual Health Services & Outcomes Research Conference
Kelsey Research Foundation
November 7, 2007, Houston, TX